| 摘要 |
The use of an agent that inhibits homologous recombination in the treatment of cancer or diseases with a hyper homologous recombination phenotype and a method of treatment of cells in a mammal, including a human, with a hyper homologous recombination phenotype comprising administering to the mammal a therapeutically effective amount of an agent that inhibits homologous recombination. |
